Ida Rosenkrands

Ida Rosenkrands

Kontakt

Ida Rosenkrands, Seniorforsker, Infektionsimmunologi / Vaccine Platforms
T. 32683721 @. idr@ssi.dk

Forskningsområder

Jeg har arbejdet med udvikling af vacciner og diagnostiske reagenser i mere end 20 år. Min nuværende forskning er fokuseret på ekspression og karakterisering af humane patogen antigener fra forskellige vaccineplatforme. Endvidere arbejder jeg med karakterisering af antistofresponset hos mennesker efter klamydiainfektion og vaccination.

Ansvarsområder

  • Afsnitsleder for Vaccineplatforme 

Udvalgte publikationer

  • Barton A, Rosenkrands I, Pickering H, Faal N, Harte A, Joof H, Makalo P, Ragonnet M, Olsen AW, Bailey RL, Mabey DCW, Follmann F, Dietrich J, Holland MJ. A systems serology approach to the investigation of infection-induced antibody responses and protection in trachoma. Front Immunol. 2023 May 23;14:1178741.

  • Christensen D, Polacek C, Sheward DJ, Hanke L, Moliner-Morro A, McInerney G, Murrell B, Hartmann KT, Jensen HE, Jungersen G, Illigen K, Isling LK, Jensen RF, Hansen JS, Rosenkrands I, Fernandez-Antunez C, Ramirez S, Follmann F, Bukh J, Pedersen GK. Protection against SARS-CoV-2 transmission by a parenteral prime-Intranasal boost vaccine strategy. EBioMedicine. 2022 Sep 5:104248.

  • Woodworth JS, Clemmensen HS, Battey H, Dijkman K, Lindenstrøm T, Laureano RS, Taplitz R, Morgan J, Aagaard C, Rosenkrands I, Lindestam Arlehamn CS, Andersen P, Mortensen R. A Mycobacterium tuberculosis-specific subunit vaccine that provides synergistic immunity upon co-administration with Bacillus Calmette-Guérin. Nat Commun. 2021 Nov 18;12(1):6658.

  • Olsen AW, Rosenkrands I, Holland MJ, Andersen P, Follmann F. A Chlamydia trachomatis VD1-MOMP vaccine elicits cross-neutralizing and protective antibodies against C/C-related complex serovars. NPJ Vaccines. 2021 Apr 19;6(1):58. doi: 10.1038/s41541-021-00312-9. Erratum in: NPJ Vaccines. 2022 Aug 30;7(1):104.

  • Grasse M, Rosenkrands I, Olsen A, Follmann F, Dietrich J. A flow cytometry-based assay to determine the phagocytic activity of both clinical and nonclinical antibody samples against Chlamydia trachomatis. Cytometry A. 2018 May;93(5):525-532.

  • Østergaard O, Follmann F, Olsen AW, Heegaard NH, Andersen P, Rosenkrands I. Quantitative Protein Profiling of Chlamydia trachomatis Growth Forms Reveals Defense Strategies Against Tryptophan Starvation. Mol Cell Proteomics. 2016 Dec;15(12):3540-3550. 

Alle publikationer: Ida Rosenkrands (0000-0003-0085-7883) - ORCID